Revvity Inc. (RVTY)

RVTY · Health Care · United States

Revvity Inc. (RVTY) is a company in the Health Care sector, based in United States. The stock is held in 10 ETFs we track – with its largest weight of 0.16 % in WDSD (msci-world-small-cap). Anyone holding one of these ETFs also owns a small indirect stake in Revvity.

Average ETF coverage: 10 of the 95 ETFs we cover hold Revvity, spread across 4 indices. That puts the stock in more ETFs than 64.5 % of the 4,334 stocks we cover.

Held in10 ETFs

Highest weight0.16 %

Indices4

SectorHealth Care

CountryUnited States

ISINUS7140461093

Data note 1

Price chart

Data note 2

Performance

Performance
Year to date	+50.6 %	1 year	+70.9 %
1 month	+25.4 %	3 months	+49.0 %
Calendar year 2025	-13.3 %

52W

Data note 3

Measured in euros, Revvity returned +53.4 % year to date and +74.9 % over one year. The gap to the dollar figures above comes from the exchange rate alone: each daily price is converted at the ECB euro reference rate for the same day.

Data note 4

Risk metrics

Max drawdown-35.6 %

Volatility p.a.37.4 %

Data note 5

Below peak0.0 %

Beta to S&P 5001.21

Correlation to S&P 5000.40

The close on Sep 16, 2026 was the highest since our series begins on Aug 12, 2024. Over the last 252 trading days, on days when the S&P 500 rose or fell 1 %, Revvity moved on average 1.21 % in the same direction. The correlation of 0.40 shows how reliable that average is: the broad market explained part of the daily moves, but far from all.

Data note 6

Correlated with

The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.

Correlated with
Instrument	r	−1 … +1
Thermo Fisher Scientific Inc.	+0.69
Mettler-Toledo International Inc.	+0.64
Waters Corporation	+0.58
Agilent Technologies Inc.	+0.57
Illumina Inc.	+0.56
Charles River Laboratories International Inc.	+0.53
Costco Wholesale Corporation	-0.25
XNO	-0.25
Charles Schwab Corp	-0.23

Data note 7

Key financials

Latest reported fiscal year (FY2025, period end 2025-12-28) as filed with the SEC.

Revenue2.9 bn $

Net income0.2 bn $

Diluted EPS2.07 $

Net margin8.4 %

Return on equity3.3 %

Equity ratio59.6 %

Revenue growth+3.7 %

Revenue and profit by fiscal year
Fiscal year	Revenue	Net income	Margin
FY2023	2.8	0.7	25.2 %
FY2024	2.8	0.3	9.8 %
FY2025	2.9	0.2	8.4 %

Data note 8

Held in these ETFs

Held in these ETFs
ETF	Index	Weight	per €1,000 in the ETF
ZPRS / WDSD	msci-world-small-cap	0.16 %	€1.60
XSWC / XSWD	msci-world-small-cap	0.15 %	€1.50
SPYI / SPSA	msci-acwi-imi	0.05 %	€0.50
SXR8	sp500	0.03 %	€0.30
SPYL / SPY5	sp500	0.02 %	€0.20
WIMI	msci-world-imi	0.01 %	€0.10

Data note 9

The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to Revvity as of the fund's latest holdings list.

Weight in SXR8 since 2023

Jun 30, 2023Sep 16, 2026

In SXR8, a fund tracking the S&P 500, Revvity had a weight of 0.04 % on Jun 30, 2023 and 0.03 % on Sep 16, 2026. Its share peaked at 0.04 % on Jun 30, 2023. The weight rises and falls with the stock's price relative to the other index members, and it also shifts when the index provider changes the composition.

Data note 10

How much Revvity Inc. overlaps with other holdings in a portfolio is shown by the Portfolio X-Ray and the ETF overlap check.

Stocks with similar ETF exposure

Names that reach a portfolio through largely the same funds as Revvity — the figure counts the ETFs holding both.

Data note 11

Key figures side by side

Key figures compared with stocks of similar ETF exposure
Stock	1 year	Volatility p.a.	Net margin	Revenue growth
Revvity	+70.9 %	37.4 %	8.4 %	+3.7 %
Align Technology	+14.1 %	46.9 %	10.2 %	+0.9 %
Baxter International	-1.4 %	41.1 %	-8.5 %	+5.7 %
Charles River Laboratories International	+80.3 %	49.3 %	-3.6 %	-0.9 %
DaVita	+49.0 %	38.8 %	7.9 %	+6.5 %
Henry Schein	+26.9 %	26.7 %	3.2 %	+4.0 %
Moderna	+486.2 %	141.2 %	-145.2 %	-39.9 %
Insulet Corporation	-57.7 %	41.5 %	9.1 %	+30.7 %
Solventum Corporation	+19.8 %	30.2 %	18.7 %	+0.9 %

Return and volatility from our daily closing prices in US dollars; margin and growth from the latest SEC annual filing. Fiscal years do not all end on the same date.